Use of BVS in ST-segment Elevation Myocardial Infarction (STEMI): the BVS STEMI STRATEGY-IT Prospective Registry
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 500 participants.
Also called NCT02601781
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 500 participants
- Sponsor
- Azienda Ospedaliera Bolognini di Seriate Bergamo
- Registry
-
NCT02601781
-
- Other papers using this trial's data
- Five-year clinical outcomes of STEMI patients treated with a pre-specified bioresorbable vascular scaffold implantation technique: Final results of the BVS STEMI STRATEGY-IT
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT02601781. Allocation not applicable; no masking; primary purpose treatment. Start 2015-10 (registry gives no type); primary completion 2016-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Use of BVS in ST-segment Elevation Myocardial Infarction (STEMI): the BVS STEMI STRATEGY-IT Prospective Registry
- Acronym
- STRATEGY-IT
- Condition
- ST-elevation Myocardial Infarction (STEMI)
- Intervention (Procedure)
- Primary percutaneous coronary intervention (PPCI)
- Intervention (Device)
- Bioresorbable Vascular Scaffold (BVS ABSORB)
- Lead sponsor
- Azienda Ospedaliera Bolognini di Seriate Bergamo
Record details
- Record id
cardio:ct-nct02601781- Content hash
40c801b16d33aea0fa6780edd0567092124915440f3553bda3ff9e3dbede5450